Replies to post #5503 on The Rising Influence of Rising Affluence

[DewDiligence]

Every other sentence on PFE’s CC is about emerging markets.

[DewDiligence]

PFE raises dividend to annualized payout of $0.96 (from prior rate of $0.88):

http://finance.yahoo.com/news/pfizer-declares-first-quarter-2013-154400550.html

At the current share price, the yield is now 3.8%.

PFE is a participant in The Global Demographic Tailwind via its large sales of branded generics in emerging markets (#msg-66847124, #msg-63363415, #msg-77289495 [see embedded links and Reply chain]).

Moreover, PFE’s animal-health business, to be called Zoetis*, will IPO in early 2013, and the 80% of Zoetis shares retained by PFE will be distributed to PFE’s own shareholders in mid 2013 (#msg-78469426, #msg-82454012). Zoetis, which has about $4B in annual sales, is a beneficiary of TGDT insofar as increasing affluence in emerging markets allows greater expenditures on both companion animals and food-stock animals.

*Pronounced zo-EH-tis.